NOVOSTIA
Novostia is a privately held medical device company incorporated in 2017 in Microcity Neuchâtel, Switzerland, developing an innovative artificial heart valve, designed for patients of any age, including children.
NOVOSTIA
Industry:
Health Care Medical Device
Founded:
2017-01-01
Address:
Neuchâtel, Neuchatel, Switzerland
Country:
Switzerland
Website Url:
http://www.novostia.com
Total Employee:
1+
Status:
Active
Total Funding:
9.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
SyMap Medical
SyMap Medical is an innovative medical device company.
ZSX Medical
ZSX Medical, LLC, is a pre-clinical stage medical device company.
Current Employees Featured
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Venture Round - Novostia
Official Site Inspections
http://www.novostia.com
- Host name: h2web80.infomaniak.ch
- IP address: 83.166.138.28
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Novostia"
Novostia SA | Novostia
Novostia is a privately held medical device company developing an innovative artificial heart valve, especially for young patients. With the support of world leading surgeons, Novostia endeavors to improve the quality of life of millions …See details»
Novostia - Crunchbase Company Profile & Funding
Novostia is a privately held medical device company incorporated in 2017 in Microcity Neuchâtel, Switzerland, developing an innovative artificial heart valve, designed for patients of any age, …See details»
Novostia Company Profile 2024: Valuation, Funding & Investors
Operator of a medical device company intended to develop an innovative artificial heart valve for patients of any age, including children.See details»
Novostia Announces New CEO Appointment and
About Novostia Novostia is a privately held medical device company incorporated in 2017 and based at iopôle in Lausanne, Switzerland, developing an innovative artificial heart valve. The …See details»
Novostia Company Profile - Office Locations, Competitors ... - Craft
Novostia is a company developing an artificial heart valve for patients of any age, including children. It offers durable, anticoagulant-free and silent heart valve prosthesis with anatomic tri …See details»
Novostia Announces New CEO and Secures Additional CHF 5.6 …
Sep 17, 2024 · Novostia is a privately held medical device company incorporated in 2017 and based at Biopôle in Lausanne, Switzerland, developing an innovative artificial heart valve. The …See details»
Novostia Secures Additional CHF 5.6 million in Funding and …
Oct 18, 2024 · Novostia is a privately held medical device company incorporated in 2017 and based at Biopôle in Lausanne, Switzerland, developing an innovative artificial heart valve. The …See details»
Novostia Announces New CEO Appointment and Secures …
Appointment of new CEO and successful fundraising for Novostia! Exogems SA, a pioneering Swiss biotech company developing innovative therapeutic exosomes derived from …See details»
Novostia Announces New CEO and Secures Additional CHF 5.6 …
Sep 17, 2024 · LAUSANNE, Switzerland, September 17, 2024 -- (BUSINESS WIRE)--Novostia, a pioneering medical technology company, specializing in the development of a disruptive heart …See details»
NEW FUNDRAISING AND OPPORTUNITY FOR A NEW …
Novostia is a privately held medical device company incorporated in 2017 in Neuchâtel, Switzerland, developing an innovative artificial heart valve. For more information, please visit …See details»
Additional CHF 5.6 million and new leadership for Novostia
Sep 19, 2024 · Novostia, which specializes in the development of a disruptive heart valve prosthesis, has completed a CHF 5.6 million funding round to further accelerate its …See details»
Novostia - Funding, Financials, Valuation & Investors - Crunchbase
Novostia is funded by 2 investors. Biopôle and Horizon 2020 are the most recent investors. in funding over 4 rounds. Their latest funding was raised on Sep 9, 2024 from a Corporate …See details»
Novostia announces new funding and leadership changes
Sep 18, 2024 · Novostia has announced a leadership transition alongside the successful completion of a CHF 5.6 million fund raise to further accelerate the company’s development …See details»
A large unmet patient need worldwide - Novostia
Novostia technology aims at improving the quality of life of all operable patients who need of a heart valve replacement, especially: Young patients. Aortic valve narrowing and/or deficiency …See details»
Novostia to launch first-in-human trials of its innovative artificial ...
May 8, 2023 · Located today on the premises of the Biopôle campus, Novostia will use the proceeds from the Series A round to initiate First-in-Human (FIH) trials for its innovative …See details»
Novostia secures CHF 5.6M for the development of its heart valve
Sep 24, 2024 · Novostia, a Lausanne-based medtech developing a breakthrough artificial heart valve, has secured an additional CHF 5.6 million in financing. This financial boost will allow the …See details»
Novostia SA - VentureRadar
Novostia is a medical technology company that specializes in the development of artificial heart valves. Their innovative product offers low thrombogenicity, lifelong durability, and a low …See details»
Novostia starts clinical trials of its new heart valve in Lituania
Nov 15, 2024 · Novostia has received the green light from the Lithuanian State Health Care Accreditation Agency under the Ministry of Health to launch the First-in-Human implantations …See details»
Russian journalist convicted of cooperating with a foreign …
2 days ago · The organization has been fined millions of dollars by Russi and was outlawed in the country in February. Alsu Kurmasheva , a Radio Free Europe/Radio Liberty journalist with U.S …See details»
Additional CHF 5.6 million and new leadership for Novostia
Sep 19, 2024 · Novostia, which specializes in the development of a disruptive heart valve prosthesis, has completed a CHF 5.6 million funding round to further accelerate its …See details»